The contradiction between the rapid growth of drug costs and the limited carrying capacity of medical insurance funds has become a major problem in the world. Through study and exploration, Taiwan has gradually formed a set of relatively perfect medical insurance drug price management and payment system, basically realizing the leap and gradual improvement from the hospital drug price plus to the drug payment price benchmark classification pricing and grouping classification adjustment. The unique policy and system design on the pricing, access and price adjustment of medical insurance can provide decision-making reference for the reform and policy design of medical insurance drug management under the background of medical insurance fee control in mainland China.